REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/02/2026
Back to search
Official data from USPTO
RYVU
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
RYVU
ST13
US500000079280613Class
1, 5, 9, 42
Filing
79280613
Registration
6279534
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
03/03/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 9, 42
Filing date
12/11/2019
Registration date
03/02/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/02/2021
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
PL
Examiner
BERNS, LEE ANNE
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ryvu Therapeutics SA
Representatives
Claudia W. Stangle Leydig, Voit & Mayer, Ltd.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations being additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposesother than for medical or veterinary use; chemical products for biotechnological purposeschemicals for use in biotechnological research and product development; chemicals for use in the agrochemical industry
Class 5
Chemico-pharmaceutical preparationschemical preparations for pharmaceutical purposesfor the treatment of cancer and for use in immunology and oncology; chemical preparations for pharmaceutical purposes for the treatment of cancer and for use in immunology and oncology; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancer; biotechnological preparations for medical use in the nature of biological preparations for the treatment of cancer and for use immunology and oncology; medicines for human purposesmedicines for the treatment of cancer and for use in immunology and oncology; adjuvants for medical purposes; biological tissue cultures for medical purposes; biological preparations being biological tissue cultures for veterinary purposes; biological preparations for medical purposesfor treatment of cancer and for use in immunology and oncology; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; medical preparationsfor treatment of cancer and for use in oncology; diagnostic preparations and materials being diagnostic preparations for medical purposes; chemical preparations for medical purposes namelyfor treatment of cancer and for use in immunology and oncology; immunomodulators being a type of pharmaceutical preparation for the treatment of cancer; immunostimulants; immunoassay reagents for medical use; chemotherapeutics; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer; mixed biological preparations for medical purposesfor the treatment of cancer; pharmaceuticals for the treatment of cancer; pharmaceutical preparations and substancesfor treatment of cancer and for use in immunology and oncology; anti-cancer preparations
Class 9
Downloadable computer software for use with medical diagnosisresearchtreatmentfor analyzing medical data and diagnosing medical conditionsfor evaluation of suggested medical treatmentanalyzing and evaluating medical data for mitigation or prevention of diseasefor processing data related to clinical trialsfor use with the developmentproductionresearch of pharmaceuticalsdata processingdata analysis and data evaluationprocessing and analyzing data related to clinical trialsevaluating and analyzing pharmaceutical ingredients and facilitating formulation and administration of pharmaceuticals
Class 42
Research and development services in the field of immunology; chemistry servicesresearch in the field of immunology and oncology; chemical laboratories; chemistry consultation; testing of chemicals; chemical analysis; scientific research relating to chemistry; chemical research laboratory services; research and development services in the field of chemistry; provision of scientific information relating to the chemical industry; preparation of reports relating to chemical research; research and development in the pharmaceutical and biotechnology fields; laboratory research services relating to pharmaceuticals; information technology consultancy services for the pharmaceutical and healthcare industries; scientific research; computer aided scientific research services; biochemical research and analysis; genetic research; clinical research in the field of immunology and oncology; biological research; biological analysis; scientific research relating to biology; custom development of biological samples for research purposes; medical research; research to develop new products; research in the field of gene therapy; research and development in the field of diagnostic preparations; information on the subject of scientific research in the field of biochemistry and biotechnology; consultancy relating to pharmaceutical research; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical products development; pharmaceutical product evaluation; testing of pharmaceuticals; conducting clinical trials for others for pharmaceutical products; research on the subject of pharmaceuticals; scientific laboratory services; scientific research services relating to the isolation and cultivation of human tissues and cells; computer aided scientific testing in the field of immunology and oncology; scientific and technological designdesign in the fields of biochemistry and biotechnologycustom design of pharmaceuticalschemicalsbiological preparationsscientific softwarepharmaceutical softwaremedical softwaremedical instruments and devices; software design and development; design and development of medical technologytechnology research in the field of medical instruments and devices; design and development of software for database management; pharmaceutical research and development; providing scientific information about the results of clinical trials for pharmaceutical products; technological researchresearch in the field of pharmaceuticals; engineering services relating to computerscomputer-aided engineering services for the biotechnology industry; computer systems analysis
Publications
History of USPTO decisions and trademark events.
36 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/20/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/02/2021
FIMP
FINAL DISPOSITION PROCESSED
06/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/02/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/15/2020
PUBO
PUBLISHED FOR OPPOSITION
12/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/11/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
11/11/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/11/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
11/11/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/11/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
10/21/2020
ALIE
ASSIGNED TO LIE
10/20/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/20/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
10/20/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/20/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/08/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2020
RFNT
REFUSAL PROCESSED BY IB
04/24/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/08/2020
RFRR
REFUSAL PROCESSED BY MPU
04/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/20/2020
CNRT
NON-FINAL ACTION WRITTEN
03/19/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/17/2020
DOCK
ASSIGNED TO EXAMINER
03/13/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/13/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/12/2020
Continuous trademark protection
Get notified about every new filing that threatens RYVU or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.